Published in Dermatoendocrinol on July 01, 2009
Age-related disease association of endogenous γ-H2AX foci in mononuclear cells derived from leukapheresis. PLoS One (2012) 0.84
No evidence for induction of key components of the Notch signaling pathway (Notch-1, Jagged-1) by treatment with UV-B, 1,25(OH)(2)D(3), and/or epigenetic drugs (TSA, 5-Aza) in human keratinocytes in vitro. Dermatoendocrinol (2012) 0.81
Unravelling of hidden secrets: The role of vitamin D in skin aging. Dermatoendocrinol (2012) 0.79
Pilot study on the bioactivity of vitamin d in the skin after oral supplementation. Cancer Prev Res (Phila) (2015) 0.78
Heme Degradation by Heme Oxygenase Protects Mitochondria but Induces ER Stress via Formed Bilirubin. Biomolecules (2015) 0.76
UVB exposure of farm animals: study on a food-based strategy to bridge the gap between current vitamin D intakes and dietary targets. PLoS One (2013) 0.75
The skin is a fascinating endocrine organ. Dermatoendocrinol (2009) 0.75
Local UV-induced DNA damage in cell nuclei results in local transcription inhibition. EMBO Rep (2001) 1.99
Regulation of terminal differentiation of cultured mouse epidermal cells by 1 alpha,25-dihydroxyvitamin D3. Endocrinology (1983) 1.59
UVB-induced conversion of 7-dehydrocholesterol to 1alpha,25-dihydroxyvitamin D3 in an in vitro human skin equivalent model. J Invest Dermatol (2001) 1.25
Neonatal human foreskin keratinocytes produce 1,25-dihydroxyvitamin D3. Biochemistry (1986) 1.17
Photoprotection by 1,25 dihydroxyvitamin D3 is associated with an increase in p53 and a decrease in nitric oxide products. J Invest Dermatol (2006) 1.14
1,25-Dihydroxyvitamin D production and receptor binding in human keratinocytes varies with differentiation. J Biol Chem (1988) 1.11
Identification of new drug sensitivity genes using genetic suppressor elements: protein arginine N-methyltransferase mediates cell sensitivity to DNA-damaging agents. Cancer Res (2003) 1.09
Mechanisms implicated in the growth regulatory effects of vitamin D compounds in breast cancer cells. Recent Results Cancer Res (2003) 1.05
Detecting ultraviolet damage in single DNA molecules by atomic force microscopy. Biophys J (2007) 1.05
1,25-Dihydroxyvitamin D3 inhibits ultraviolet B-induced apoptosis, Jun kinase activation, and interleukin-6 production in primary human keratinocytes. J Cell Biochem (2003) 1.04
1,25-Dihydroxyvitamin D3 and analogues protect primary human keratinocytes against UVB-induced DNA damage. J Photochem Photobiol B (2005) 1.00
Stimulation versus inhibition of keratinocyte growth by 1,25-Dihydroxyvitamin D3: dependence on cell culture conditions. J Invest Dermatol (1996) 0.98
1,25(OH)2 vitamin D3 induces elevated expression of the cell cycle-regulating genes P21 and P27 in squamous carcinoma cell lines of the head and neck. Acta Otolaryngol (2001) 0.97
Two 14-epi analogues of 1,25-dihydroxyvitamin D3 protect human keratinocytes against the effects of UVB. Arch Dermatol Res (2004) 0.90
The photoprotective effect of 1,25-dihydroxyvitamin D3 on ultraviolet light B-induced damage in keratinocyte and its mechanism of action. J Dermatol Sci (1998) 0.89
Cutaneous photosynthesis of vitamin D: an evolutionary highly-conserved endocrine system that protects against environmental hazards including UV-radiation and microbial infections. Anticancer Res (2006) 0.89
1,25-Dihydroxyvitamin D3 increases the growth-promoting activity of autocrine epidermal growth factor receptor ligands in keratinocytes. Endocrinology (1999) 0.86
Squamous cell carcinomas fail to respond to the prodifferentiating actions of 1,25(OH)2D: why? Recent Results Cancer Res (2003) 0.84
Vitamin D induced up-regulation of keratinocyte growth factor (FGF-7/KGF) in MCF-7 human breast cancer cells. Biochem Biophys Res Commun (2000) 0.81
Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients. J Am Acad Dermatol (2005) 3.04
Autocrine formation of hepcidin induces iron retention in human monocytes. Blood (2007) 2.50
Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood (2009) 2.41
Down-regulation of HLA class II and costimulatory CD86/B7-2 on circulating monocytes from melanoma patients. Cancer Immunol Immunother (2004) 2.12
The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res (2009) 1.90
In vitro drug sensitivity predicts response and survival after individualized sensitivity-directed chemotherapy in metastatic melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group. Clin Cancer Res (2006) 1.86
Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats. Blood (2011) 1.63
The arachidonic acid metabolome serves as a conserved regulator of cholesterol metabolism. Cell Metab (2014) 1.47
Absence of functional Hfe protects mice from invasive Salmonella enterica serovar Typhimurium infection via induction of lipocalin-2. Blood (2009) 1.40
UV damage and DNA repair in malignant melanoma and nonmelanoma skin cancer. Adv Exp Med Biol (2008) 1.35
High-throughput miRNA profiling of human melanoma blood samples. BMC Cancer (2010) 1.32
Analysis of the vitamin D system in cervical carcinomas, breast cancer and ovarian cancer. Recent Results Cancer Res (2003) 1.28
Temozolomide in combination with interferon-alfa versus temozolomide alone in patients with advanced metastatic melanoma: a randomized, phase III, multicenter study from the Dermatologic Cooperative Oncology Group. J Clin Oncol (2005) 1.27
Frontiers in sebaceous gland biology and pathology. Exp Dermatol (2008) 1.27
Estimated benefit of increased vitamin D status in reducing the economic burden of disease in western Europe. Prog Biophys Mol Biol (2009) 1.26
Pyoderma gangrenosum: clinical presentation and outcome in 18 cases and review of the literature. J Dtsch Dermatol Ges (2007) 1.24
In vitro comparison of the vitamin D endocrine system in 1,25(OH)2D3-responsive and -resistant melanoma cells. Cancer Biol Ther (2007) 1.18
Dysregulated monocyte iron homeostasis and erythropoietin formation in patients with anemia of chronic disease. Blood (2006) 1.18
Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases. Am J Clin Dermatol (2008) 1.16
Differential biological effects of 1,25-dihydroxyVitamin D3 on melanoma cell lines in vitro. J Steroid Biochem Mol Biol (2004) 1.12
ADAM10 is upregulated in melanoma metastasis compared with primary melanoma. J Invest Dermatol (2009) 1.11
Characterization of the vitamin D endocrine system in human sebocytes in vitro. J Steroid Biochem Mol Biol (2008) 1.08
Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease. Gastroenterology (2008) 1.07
Vitamin D and skin: new aspects for dermatology. Exp Dermatol (2004) 1.04
Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma. Melanoma Res (2007) 1.04
L1 adhesion molecule (CD 171) in development and progression of human malignant melanoma. Cancer Lett (2003) 1.03
Activation of vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling pathways through 1,25(OH)(2)D(3) in melanoma cell lines and other skin-derived cell lines. Dermatoendocrinol (2009) 1.03
Growth differentiation factor 15 in anaemia of chronic disease, iron deficiency anaemia and mixed type anaemia. Br J Haematol (2009) 1.03
Vitamin D receptor (VDR) polymorphisms and skin cancer: A systematic review. Dermatoendocrinol (2011) 1.02
Analysis of the vitamin D system in cutaneous malignancies. Recent Results Cancer Res (2003) 1.01
Transcriptional profiling of human endogenous retrovirus group HERV-K(HML-2) loci in melanoma. Genome Biol Evol (2013) 1.01
Severe nail changes due to Docetaxel treatment. Eur J Dermatol (2004) 1.00
Analysis of the vitamin D system in cutaneous squamous cell carcinomas. J Cutan Pathol (2004) 1.00
Changing a concept--controversy on the confusing spectrum of the reticulate pigmented disorders of the skin. J Cutan Pathol (2008) 1.00
Pathways for the regulation of hepcidin expression in anemia of chronic disease and iron deficiency anemia in vivo. Haematologica (2011) 0.99
Bilateral multifocal chorioretinopathy in a woman with cutaneous malignant melanoma. Arch Ophthalmol (2002) 0.99
Analysis of the vitamin D system in basal cell carcinomas (BCCs). Lab Invest (2004) 0.98
Sunlight vitamin D and skin cancer. Anticancer Agents Med Chem (2013) 0.97
Impact of iron treatment on immune effector function and cellular iron status of circulating monocytes in dialysis patients. Nephrol Dial Transplant (2010) 0.96
Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative setting. Melanoma Res (2008) 0.96
Evidence and interdisciplinary consensus-based German guidelines: surgical treatment and radiotherapy of melanoma. Melanoma Res (2008) 0.95
Analysis of vitamin D-receptor (VDR) and retinoid X-receptor alpha in breast cancer. Histochem J (2002) 0.95
25-hydroxyvitamin D deficiency in renal transplant recipients. J Clin Endocrinol Metab (2005) 0.95
Human endogenous retrovirus HERV-K(HML-2) proviruses with Rec protein coding capacity and transcriptional activity. Virology (2004) 0.94
Short German guidelines: malignant melanoma. J Dtsch Dermatol Ges (2008) 0.94
Recurring mixed-type neurothekeoma of the face. Dermatoendocrinol (2009) 0.93
Comparable effectiveness of endovenous laser ablation and high ligation with stripping of the great saphenous vein: two-year results of a randomized clinical trial (RELACS study). Arch Dermatol (2011) 0.92
Successful desensitization with human insulin in a patient with an insulin allergy and hypersensitivity to protamine: a case report. J Med Case Rep (2008) 0.92
Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells. Anticancer Res (2009) 0.92
Human endogenous retrovirus HERV-K(HML-2) Rec expression and transcriptional activities in normal and rheumatoid arthritis synovia. J Rheumatol (2006) 0.91
The role of the human DNA mismatch repair gene hMSH2 in DNA repair, cell cycle control and apoptosis: implications for pathogenesis, progression and therapy of cancer. J Mol Histol (2006) 0.91
Peroxisome proliferator-activated receptors (PPARs) in dermatology: Challenge and promise. Dermatoendocrinol (2011) 0.90
Vitamin D(3) metabolism in human glioblastoma multiforme: functionality of CYP27B1 splice variants, metabolism of calcidiol, and effect of calcitriol. Clin Cancer Res (2005) 0.90
Cutaneous photosynthesis of vitamin D: an evolutionary highly-conserved endocrine system that protects against environmental hazards including UV-radiation and microbial infections. Anticancer Res (2006) 0.89
Prospective randomized trial of interferon alfa-2b and interleukin-2 as adjuvant treatment for resected intermediate- and high-risk primary melanoma without clinically detectable node metastasis. J Clin Oncol (2003) 0.89
Rosette formation in melanoma: more frequent than suspected? Am J Dermatopathol (2003) 0.89
No evidence for reduced 25-hydroxyvitamin D serum level in melanoma patients. Cancer Causes Control (2004) 0.89
Iron absorption and distribution in TNF(DeltaARE/+) mice, a model of chronic inflammation. J Trace Elem Med Biol (2009) 0.88
Immunohistochemical analysis of 1,25-dihydroxyvitamin-D3-receptors, estrogen and progesterone receptors and Ki-67 in ovarian carcinoma. Anticancer Res (2002) 0.88
Analysis of 25-hydroxyvitamin D3-1alpha-hydroxylase in normal and malignant breast tissue. Anticancer Res (2006) 0.88
Signature of VDR miRNAs and epigenetic modulation of vitamin D signaling in melanoma cell lines. Anticancer Res (2012) 0.87
Expression analysis of CYP27B1 in tumor biopsies and cell cultures. Anticancer Res (2006) 0.87
Treosulfan and gemcitabine in metastatic uveal melanoma patients: results of a multicenter feasibility study. Anticancer Drugs (2003) 0.87
Leucocytoclastic vasculitis associated with acquired reactive perforating collagenosis: A diagnostic mimicry. Dermatoendocrinol (2009) 0.87
The DNA-mismatch repair enzyme hMSH2 modulates UV-B-induced cell cycle arrest and apoptosis in melanoma cells. J Invest Dermatol (2007) 0.86
Expression of 25-hydroxyvitamin D-1alpha-hydroxylase (1alphaOHase, CYP27B1) splice variants in HaCaT keratinocytes and other skin cells: modulation by culture conditions and UV-B treatment in vitro. Anticancer Res (2009) 0.86
Skin manifestations in tumor necrosis factor receptor-associated periodic syndrome (TRAPS). Dermatoendocrinol (2010) 0.86
Chemosensitivity testing in malignant melanoma. Recent Results Cancer Res (2003) 0.86
Neutrophil gelatinase-associated lipocalin and interleukin-10 regulate intramacrophage Chlamydia pneumoniae replication by modulating intracellular iron homeostasis. Immunobiology (2012) 0.85
Peroxisome proliferator-activated receptor (PPAR) and vitamin D receptor (VDR) signaling pathways in melanoma cells: promising new therapeutic targets? J Steroid Biochem Mol Biol (2010) 0.85
Vitamin D deficiency during pregnancy: a risk factor not only for fetal growth and bone metabolism but also for correct development of the fetal immune system? Am J Clin Nutr (2005) 0.85
Vitamin D analogs in the treatment of psoriasis: Where are we standing and where will we be going? Dermatoendocrinol (2011) 0.85
Depressive mood changes and psychiatric symptoms during 12-month low-dose interferon-alpha treatment in patients with malignant melanoma: results from the multicenter DeCOG trial. J Immunother (2010) 0.84